AstraZeneca, Merck ovarian cancer treatment improves progression-free survival
AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian
AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian